AUGUSTASIA BUSINESS OUTLOOK9NEWSROOMDKSH & KYOWA KIRIN PARTNER TO TRANSFORM BUSINESS IN APAC REGIONNexif Ratch Energy (NRE), a leading independent power producer specializing in renewable energy solutions, has announced that the Calabanga Solar Project (CARE) in Camarines Sur, South Luzon, Philippines, officially commenced commercial operations on August 5, 2024. This milestone was achieved following a rigorous testing and commissioning process conducted by the National Grid Corporation of the Philippines.CARE is a 74.2 MWp ground-mounted solar PV project, representing the first utility-scale solar power initiative in the Bicol Region. It will supply clean energy to the national grid, with the majority of its electricity output sold under a 10-year Power Supply Agreement with a subsidiary of the Aboitiz Power Corporation Group, ensuring a stable revenue stream. NRE is committed to the Philippine renewable energy sector and is currently developing the 145 MWp NPSI solar project in Visayas. Additionally, the company is advancing several wind energy initiatives, including the San Miguel Bay nearshore wind project with a capacity of up to 500 MW and the Lucena offshore wind project with a capacity of up to 450 MW.Cyril Dissescou, CEO of Nexif Ratch Energy, expressed his enthusiasm, stating, "We are delighted to announce the successful commercial operation of the Calabanga Solar Project, our first operating project in the Philippines. CARE demonstrates our commitment to delivering reliable and sustainable energy solutions, contributing to the Philippines' renewable energy objectives." Surender Singh, Chairman of Nexif Ratch Energy, added, "We appreciate the support from the Government of the Philippines and the collaboration of our partners, lenders, and the local communities in Camarines Sur. With the COD of CARE and the strong progress we are making on other projects in target markets, we remain on track with our planned growth trajectory.". DKSH Business Unit Healthcare, a key player in market expansion services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, collaborates with Kyowa Kirin Co., Ltd, a global specialty pharmaceutical company from Japan, to support Kyowa Kirin's business transformation in Asia-Pacific.The partnership includes a deal for commercial rights of Kyowa Kirin's medicines in South Korea, Taiwan, Singapore, Thailand, Malaysia, Hong Kong & Macau SAR, and global products Crysvita® in Singapore, Thailand, Malaysia, Hong Kong & Macau SAR and Poteligeo® in Singapore.DKSH has been selected by Kyowa Kirin as its strategic partner to implement a full agency alliance business model that provides a complete range of integrated solutions to support sustainable growth for client partners, prioritizing healthcare access to patients. DKSH's extensive knowledge in nephrology, strong distribution channels, and solid commercial skills make this partnership a significant advancement in enhancing patient care and access in the region."We are very confident about this new journey with DKSH", stated Abdul Mullick, Ph.D., Chief International Business Officer (CIBO), Kyowa Kirin. "Given DKSH's proven healthcare expertise and commercial strength across Southeast Asia and North Asia, we are convinced we have chosen the right business partner to continue serving our patients, taking care of our employees and making people smile.". PHILIPPINES COMMENCES OPERATIONS OF ITS FIRST SOLAR POWER INITIATIVEAUGUSTASIA BUSINESS OUTLOOK9
< Page 8 | Page 10 >